Clinical Trials on Moderate to Severe Plaque-type Psoriasis in France
Total 43 results
-
Fresenius Kabi SwissBioSim GmbHMerck KGaA, Darmstadt, GermanyCompletedPsoriasis | Moderate to Severe Plaque Psoriasis | Plaque Type PsoriasisUnited States, Canada, Czechia, Hungary, Russian Federation, Bulgaria, Mexico, United Kingdom, Poland, Germany, Estonia, France
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Estonia, France, Canada
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Spain, Turkey, United Kingdom
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
IpsenCompletedModerate to Severe Glabellar LinesFrance, Germany
-
Novartis PharmaceuticalsCompletedChronic Severe Plaque-type PsoriasisBelgium, Italy, Egypt, France, Hungary, Russian Federation, Germany, Israel, Spain, Japan, Estonia, United Kingdom, Poland, Colombia, United States, Latvia, Guatemala, Romania, Switzerland
-
Kristian Reich, MDLEO PharmaCompletedMild to Moderate PsoriasisUnited Kingdom, Germany, France, Spain, Netherlands, Sweden, Italy, Denmark
-
IpsenRecruitingModerate to Severe Upper Facial LinesGermany, France
-
Pierre Fabre Dermo CosmetiqueCompletedChronic Pruritus Due to Plaque PsoriasisSpain, France
-
Assistance Publique - Hôpitaux de ParisRecruitingPatients Referred for an Isolated or a Combined Surgical Correction of Functional Moderate to Severe TricuspidFrance
-
Assistance Publique - Hôpitaux de ParisThe Paul Bennetot FoundationCompletedModerate to Severe DementiaFrance
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisUnited States, Austria, Germany, France, Japan, Canada, Slovakia, India
-
Santen SASCompletedModerate to Severe Dry Eye SyndromeFrance
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisGermany, United States, Japan, France, Norway, Israel, Iceland
-
SandozHexal AGCompletedPlaque Type PsoriasisUnited States, France, Bulgaria, Slovakia
-
Novartis PharmaceuticalsCompletedChronic Plaque-type PsoriasisGermany, United States, Japan, France, Israel, Norway, Iceland
-
Assistance Publique - Hôpitaux de ParisRecruitingModerate to Severe Traumatic Brain InjuryFrance
-
Novartis PharmaceuticalsCompletedChronic Plaque Type PsoriasisGermany, United States, Belgium, Korea, Republic of, Spain, Taiwan, Australia, Austria, Italy, Estonia, Israel, Bulgaria, Netherlands, France, Switzerland, Portugal, Slovakia, Norway, United Kingdom, Hungary, Turkey, Canada, Denmark, ...
-
Novartis PharmaceuticalsCompletedPlaque-type PsoriasisGermany, United States, France, Estonia, Canada
-
Nantes University HospitalCompletedModerate to Severe Traumatic Brain InjuryFrance
-
Egalet LtdCompletedModerate-to-severe Chronic Low Back PainUnited States
-
Hospices Civils de LyonCompletedModerate to Severe Traumatic Brain InjuryFrance
-
Institut de Sante Publique, d'Epidemiologie et...CompletedAlzheimer Disease or Associated Disorder | Mild to Moderately Severe DementiaFrance
-
Humanigen, Inc.CompletedModerate-to-Severe AsthmaFrance, United Kingdom, United States, Australia, Poland, Ukraine
-
Hoffmann-La RochePfizerCompletedModerate to Severe Ulcerative ColitisUnited States, Australia, Thailand, Poland, Russian Federation, Japan, Colombia, Spain, Turkey, Romania, India, Slovakia, France, Hungary, South Africa, Belgium, Bulgaria, Germany, Italy, Mexico, Serbia, Ukraine, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
medac GmbHRecruitingModerate to Severe Atopic DermatitisFrance, Poland, Italy, Czechia
-
Merz Therapeutics GmbHRecruitingModerate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve InjuryBulgaria, Germany, Poland, France, Hungary, Spain
-
Inmagene LLCTerminatedAtopic Dermatitis | Moderate-to-severe Atopic Dermatitis | ADCanada, United States
-
Hospices Civils de LyonUnknownCOVID-19 Disease | Patients Hospitalized in the Hospices Civils of Lyon | Moderate to Severe Dyspnea | Without Resuscitation Objective ManagementFrance
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Belgium, Bulgaria, Estonia, France, Georgia, Germany, Hungary, Italy, Poland, Singapore
-
Assistance Publique Hopitaux De MarseilleNot yet recruitingModerate to Severe Acute Respiratory Distress SyndromeFrance
-
Novartis PharmaceuticalsGenentech, Inc.CompletedModerate to Severe Allergic AsthmaUnited States, Puerto Rico
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
Assistance Publique - Hôpitaux de ParisGustave Roussy, Cancer Campus, Grand ParisNot yet recruitingMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Old Age | Severe/Moderate CoronavirusFrance